Cargando…
The long-term efficacy and safety of new biological therapies for psoriasis
Long-term therapy is often required for psoriasis. This article reviews the most recent long-term clinical data for biological agents that have been approved or for which late-stage development data have been released for the treatment of patients with moderate to severe plaque psoriasis. Efficacy d...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1461773/ https://www.ncbi.nlm.nih.gov/pubmed/16691429 http://dx.doi.org/10.1007/s00403-006-0660-6 |